Correlation Between Beta Drugs and Himadri Speciality

Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Himadri Speciality at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Himadri Speciality into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beta Drugs and Himadri Speciality Chemical, you can compare the effects of market volatilities on Beta Drugs and Himadri Speciality and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Himadri Speciality. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Himadri Speciality.

Diversification Opportunities for Beta Drugs and Himadri Speciality

-0.69

Correlation Coefficient

Beta Drugs  Himadri Speciality

Excellent diversification

The 3 months correlation between Beta and Himadri is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Himadri Speciality Chemical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Himadri Speciality and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Himadri Speciality. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Himadri Speciality has no effect on the direction of Beta Drugs i.e., Beta Drugs and Himadri Speciality go up and down completely randomly.

Pair Corralation between Beta Drugs and Himadri Speciality

Assuming the 90 days trading horizon Beta Drugs is expected to under-perform the Himadri Speciality. In addition to that, Beta Drugs is 1.64 times more volatile than Himadri Speciality Chemical. It trades about -0.07 of its total potential returns per unit of risk. Himadri Speciality Chemical is currently generating about 0.35 per unit of volatility. If you would invest  52,405  in Himadri Speciality Chemical on September 29, 2024 and sell it today you would earn a total of  4,890  from holding Himadri Speciality Chemical or generate 9.33% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Beta Drugs  vs.  Himadri Speciality Chemical

Beta Drugs

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Himadri Speciality

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Himadri Speciality Chemical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Beta Drugs and Himadri Speciality

The main advantage of trading using opposite Beta Drugs and Himadri Speciality positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Himadri Speciality can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Himadri Speciality will offset losses from the drop in Himadri Speciality's long position.

The idea behind Beta Drugs and Himadri Speciality Chemical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.